Head to Head Analysis: Know Labs (KNWN) and Its Peers

Know Labs (OTCMKTS:KNWN – Get Rating) is one of 28 publicly-traded companies in the “Measuring & controlling devices, not elsewhere classified” industry, but how does it weigh in compared to its rivals? We will compare Know Labs to related businesses based on the strength of its institutional ownership, earnings, risk, profitability, valuation, analyst recommendations and dividends.

Earnings & Valuation

This table compares Know Labs and its rivals top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Know Labs	$120,000.00	-$25.36 million	-1.89
Know Labs Competitors	$2.66 billion	$435.24 million	11.41

Know Labs’ rivals have higher revenue and earnings than Know Labs. Know Labs is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Volatility and Risk

Know Labs has a beta of 3.04, meaning that its share price is 204% more volatile than the S&P 500. Comparatively, Know Labs’ rivals have a beta of 1.03, meaning that their average share price is 3% more volatile than the S&P 500.

Insider and Institutional Ownership

10.6% of Know Labs shares are owned by institutional investors. Comparatively, 61.0% of shares of all “Measuring & controlling devices, not elsewhere classified” companies are owned by institutional investors. 44.0% of Know Labs shares are owned by insiders. Comparatively, 16.1% of shares of all “Measuring & controlling devices, not elsewhere classified” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of recent recommendations for Know Labs and its rivals, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Know Labs	0	0	1	0	3.00
Know Labs Competitors	154	690	954	28	2.47

Know Labs presently has a consensus price target of $7.00, suggesting a potential upside of 363.58%. As a group, “Measuring & controlling devices, not elsewhere classified” companies have a potential upside of 21.59%. Given Know Labs’ stronger consensus rating and higher possible upside, research analysts plainly believe Know Labs is more favorable than its rivals.

Profitability

This table compares Know Labs and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Know Labs	N/A	-968.13%	-192.31%
Know Labs Competitors	-3,288.70%	4.83%	1.80%

Summary

Know Labs rivals beat Know Labs on 7 of the 13 factors compared.

About Know Labs (Get Rating)

Know Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States. Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The company refers to its technology as Bio-RFID. The Bio-RFID technology can be integrated into various wearable, mobile, or bench-top form factors. Its first application of Bio-RFID technology is a product marketed as a glucose monitor that provide the user with real time information on their blood glucose levels. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.